secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASTROTECH Corp (ASTC)
CIK:        0001001907
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001437749-22-026776
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrotech reports Q1 FY2023 revenue of $38K, authorizes $1M share repurchase
----------------------------------------------------------------------------

- Revenue $38K for Q1 FY2023, down from prior year due to shift from ETD to AgLAB-1000-D2 commercialization.
- Cash and liquid investments total $48.9M, supporting R&D, organic growth, and potential acquisitions.
- Board authorized $1M share repurchase program from Nov 17, 2022 through Nov 17, 2023.
- BreathTech subsidiary contracts clinical research firm to collect breath samples; BreathTest-1000 shows discrimination ability.
- AgLAB-1000-D2 field trials promising; first production run started and sales efforts underway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/0001437749-22-026776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/astc20221107_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-026776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer